Table 1.
Patient ID | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 |
---|---|---|---|---|---|
Gender | Female | Female | Male | Male | Male |
Age | 51 | 51 | 54 | 45 | 53 |
Weight | 94 | 70 | 88 | 95 | 102 |
Initial vital signs (base) | |||||
RR breaths/min | 22 | 28 | 42 | 36 | 28 |
PR beats/min | 71 | 92 | 89 | 66 | 92 |
Sys BP, mmHg | 141 | 103 | 124 | 139 | 138 |
Dias BP, mmHg | 76 | 71 | 89 | 90 | 97 |
Temp > 37.3 (°C, baseline) | 37 | 37.3 | 36.7 | 37.4 | 36.2 |
SO2 (without oxygen mask) | 87 | 70 | 79 | 80 | 89 |
Other | |||||
COVID type | Sev | Sev | Sev | Sev | Sev |
Comorbidities | Fatty liver disease | HTN | Damaged lung | No | Diabetes |
Interval between symptoms onset and admission (days) | 6 | 10 | 11 | 13 | 4 |
Interval between symptoms onset and first cell injection (days) | 10 | 14 | 13 | 17 | 7 |
Duration of hospitalization in ICU after cell injection | 7 | 5 | 0 | 6 | 0 |
Conventional therapy | Hep/Dexa | Hep/Dexa | Hep/Dexa | Hep/Dexa | Hep/Dexa/Ataz |
RT-PCR at admission | + | + | + | + | + |
Sev severe, HTN hypertension, Hep heparin, Dexa dexamethasone, Ataz atazanavir, RT-PCR reverse transcription polymerase chain reaction